top of page

PASI Reductions for an Oral TYK2 Inhibitor

Dr. Ronald B. Vender reviews a poster about the TYK2 inhibitor deucravacitinib at the World Congress of Dermatology 2023 in Singapore.



12 views0 comments

Comments


bottom of page